跳至主要内容
临床试验/NCT02254629
NCT02254629已完成1 期

The Effects of Laxative-probiotic Sequential Treatment on the Symptoms and Fecal Microbiota in the IBS Patients.

Shandong University1 个研究点 分布在 1 个国家目标入组 56 人开始时间: 2014年7月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
1 期
状态
已完成
发起方
入组人数
56
试验地点
1
主要终点
Subject's Global Assessment of Relief

研究概览

简要总结

the laxative-probiotic sequential treatment might reduce the symptoms of IBS and alter the fecal microbiota of the patients in a more robust manner .

详细描述

Probiotics can regulate intestinal immunity, repair mucosal barrier, and reportedly exert therapeutic effects on IBS patients. The laxatives could also alter the gut microflora significantly, thus the laxative-probiotic sequential treatment might affect the symptoms and the composition of fecal microbiota in the IBS patients in a more robust manner .

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • the presence of Rome III criteria for IBS ;
  • Patients scheduled for colonoscopy examination or having negative screening examinations
  • Aged between 18 and 65 years old

排除标准

  • Antibiotic, probiotic or laxative usage within 4 weeks.
  • organic gastrointestinal diseases
  • Severe systematic disease: diabetes mellitus, hepatic, renal or cardiac dysfunction, thyroid disease or tumor etc.
  • pregnancy or lactation.
  • previous major or complicated abdominal surgery.
  • severe endometriosis and dementia

研究组 & 干预措施

laxative-probiotic sequential

Experimental

laxative:2000 ml. Probiotic:2 tablets/ times, 3 times / day for the first 2 weeks,immediately after colonoscopy

干预措施: Probiotic Clostridium Butyricum (Drug)

laxative-probiotic sequential

Experimental

laxative:2000 ml. Probiotic:2 tablets/ times, 3 times / day for the first 2 weeks,immediately after colonoscopy

干预措施: Laxative Polyethylene Glycol (Drug)

probiotic

Active Comparator

Probiotic:2 tablets/ times, 3 times / day for the first 2 weeks.

干预措施: Probiotic Clostridium Butyricum (Drug)

Laxative followed by Probiotic 2 weeks later

Active Comparator

laxative:2000 ml. Probiotic:2 tablets/ times, 3 times / day for the last 2 weeks with two weeks interval after colonoscopy.

干预措施: Probiotic Clostridium Butyricum (Drug)

Laxative followed by Probiotic 2 weeks later

Active Comparator

laxative:2000 ml. Probiotic:2 tablets/ times, 3 times / day for the last 2 weeks with two weeks interval after colonoscopy.

干预措施: Laxative Polyethylene Glycol (Drug)

结局指标

主要结局

Subject's Global Assessment of Relief

时间窗: 8 months

The SGA (subjective global assessment) of Relief was assessed by answering the following question: "Please consider how you felt this past week in regard to your IBS, in particular your overall wellbeing, symptoms and altered bowel habit. Compared to the way you usually felt before entering the study, how would you rate your relief of symptoms during the past week?" The scale contained five possible answers: (1) completely relieved, (2) considerably relieved, (3) somewhat relieved, (4) unchanged, or (5) worse.

次要结局

  • The changes of symptom scores(8 months)
  • IBS patients'quality of life(8 months)
  • Composition of Microorganisms in stool(8 months)

研究者

发起方
Shandong University
申办方类型
Other
责任方
Principal Investigator
主要研究者

Yanqing Li

Vice president of Qilu Hospital

Shandong University

研究点 (1)

Loading locations...

相似试验